Related Experiment Videos
Overview: toward a dysregulation hypothesis of depression
The American Journal of Psychiatry
|September 1, 1985
Summary
Neurotransmitter systems in affective disorders may be better understood as dysregulation, not just changes in activity. This model suggests impaired regulation creates vulnerability to unstable neurotransmitter output, particularly in depression.
Area of Science:
- Neuroscience
- Psychiatry
- Neurobiology
Background:
- Affective disorders and psychiatric syndromes are complex conditions.
- Current understanding often focuses on neurotransmitter levels (increases/decreases).
- A regulatory failure perspective offers a novel framework.
Purpose of the Study:
- To propose a model of "dysregulation" for neurotransmitter systems in psychiatric disorders.
- To examine evidence for noradrenergic system dysregulation in depression.
- To suggest a specific pattern of noradrenergic dysregulation in certain depressive subtypes.
Main Methods:
- Literature review of clinical and animal model studies.
- Examination of evidence against criteria for a dysregulation model.
- Theoretical model development.
Main Results:
- A "dysregulation" model posits impaired homeostatic mechanisms confer vulnerability.
- Evidence supports noradrenergic system dysregulation in depression.
- A specific configuration of noradrenergic dysregulation is proposed for some depression types.
Conclusions:
- Neurotransmitter system activity in affective disorders may reflect regulatory failure.
- Dysregulation, not just altered levels, is key to understanding vulnerability.
- Noradrenergic dysregulation is implicated in specific forms of depression.